Literature DB >> 25838692

Von recklinghausens disease: a series of four cases with variable expression.

K P Arun1, P Thomas Joseph2, H P Jaishankar3, M S Abhinethra4.   

Abstract

Though neurofibromatosis type I (NFI) is a fairly common condition, it has a variable expressivity and penetrance. Here we present a series of cases with striking differences in the presentation especially in the oral cavity. NFI, also known as von Recklinghausen's neurofibromatosis, is an autosomal dominantly inherited neurogenetic disorder affecting 1:3000 newborn (Bongiorno et al., Oral Dis 12:125-129, 2006). About 50 % of NFI patients have no family history of the disease. There is no prevalence for gender or race in NFI. Expressivity in NFI is tremendously variable, but subtle phenotypic patterns may exist within subgroups of affected patients. Furthermore, 50 % of cases are sporadic and arise from germ cell mutation (Bongiorno et al., Oral Dis 12:125-129, 2006). The precise constellation of findings in any one individual is extremely variable, both within a family and between different families (Batsakis, Tumors of the head and neck: clinical and pathological considerations, 2nd edn. Williams and Wilkins, Baltimore, pp 313-333, 1979). Only 4-7 % of patients affected by neurofibromatosis exhibit oral manifestations (Güneri et al., Turk J Pediatr 48(2):155-158, 2006).

Entities:  

Keywords:  Auxillary freckling; Cafe au lait spots; Neurofibromatosis I; Von Recklinghausens disease

Year:  2013        PMID: 25838692      PMCID: PMC4379272          DOI: 10.1007/s12663-012-0399-x

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  19 in total

1.  Benign and malignant pathology in neurofibromatosis type 1.

Authors:  Melanie Walker; Patrik Gabikian
Journal:  Neurology       Date:  2006-09-26       Impact factor: 9.910

Review 2.  Recent insights into neurofibromatosis type 1: clear genetic progress.

Authors:  D H Gutmann
Journal:  Arch Neurol       Date:  1998-06

3.  Neurological complications of neurofibromatosis type 1 in adulthood.

Authors:  A Créange; J Zeller; S Rostaing-Rigattieri; P Brugières; J D Degos; J Revuz; P Wolkenstein
Journal:  Brain       Date:  1999-03       Impact factor: 13.501

4.  Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1.

Authors:  R E Ferner; J D Lucas; M J O'Doherty; R A Hughes; M A Smith; B F Cronin; J Bingham
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

5.  Malignant peripheral nerve sheath tumours in neurofibromatosis 1.

Authors:  D G R Evans; M E Baser; J McGaughran; S Sharif; E Howard; A Moran
Journal:  J Med Genet       Date:  2002-05       Impact factor: 6.318

6.  Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force.

Authors:  R Listernick; D N Louis; R J Packer; D H Gutmann
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

7.  Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients.

Authors:  J M Friedman; P H Birch
Journal:  Am J Med Genet       Date:  1997-05-16

Review 8.  Plexiform neurofibroma of the tongue: a case report of a child.

Authors:  Enis Alpin Güneri; Ertap Akoğlu; Semih Sütay; Kerim Ceryan; Ozgül Sağol; Uğur Pabuçcuoğlu
Journal:  Turk J Pediatr       Date:  2006 Apr-Jun       Impact factor: 0.552

9.  Radiological findings in jaws and skull of neurofibromatosis type 1 patients.

Authors:  I Kaplan; S Calderon; I Kaffe
Journal:  Dentomaxillofac Radiol       Date:  1994-11       Impact factor: 2.419

10.  Manifestations of the tongue in Neurofibromatosis type 1.

Authors:  M R Bongiorno; G Pistone; M Aricò
Journal:  Oral Dis       Date:  2006-03       Impact factor: 3.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.